CS
TNON icon

Clear Street’s Tenon Medical TNON Stock Holding History

Clear Street’s Portfolio TNON Stock Details TNON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-261
Closed -$1.11K – 626
2024
Q3 		$1.11K Buy
+261
New +$1.26K ﹤0.01% 586

Other funds holding TNON

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SAMC
Spectrum Asset Management (California) Newport Beach, California $315M AUM 19.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Clear Street's TNON Position: Q4 2024 in Review

Clear Street sold out of Tenon Medical (TNON) in Q4 2024, closing a stake of 261 shares — an estimated $1.11K sold.

Clear Street first reported a position in TNON in Q3 2024 and held it in 1 quarter. The position peaked at $1.11K in Q3 2024. 12 funds tracked by Wall St. Rank hold TNON as of Q4 2024.

  • Clear Street reported no remaining Tenon Medical position as of Q4 2024 after selling out during the quarter.
  • Clear Street sold 261 Tenon Medical shares in Q4 2024, an estimated $1.11K.
  • Clear Street first reported a position in Tenon Medical in Q3 2024 and held it in 1 quarter.
  • Clear Street's Tenon Medical position peaked at $1.11K in Q3 2024.
  • 12 funds tracked by Wall St. Rank held Tenon Medical as of Q4 2024.

Based on Clear Street's 13F filing for Q4 2024, filed 14 Feb 2025.